Innoviva, Inc. (INVA): Price and Financial Metrics
GET POWR RATINGS... FREE!
INVA POWR Grades
- INVA scores best on the Value dimension, with a Value rank ahead of 94.46% of US stocks.
- INVA's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
- INVA's current lowest rank is in the Momentum metric (where it is better than 11.35% of US stocks).
INVA Stock Summary
- INVA's current price/earnings ratio is 4.26, which is higher than just 4.17% of US stocks with positive earnings.
- The ratio of debt to operating expenses for Innoviva Inc is higher than it is for about 96.39% of US stocks.
- Innoviva Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 34.92%, greater than the shareholder yield of 93.07% of stocks in our set.
- Stocks that are quantitatively similar to INVA, based on their financial statements, market capitalization, and price volatility, are TRN, HTGC, NOVA, CSV, and SPR.
- Visit INVA's SEC page to see the company's official filings. To visit the company's web site, go to www.inva.com.
INVA Valuation Summary
- INVA's price/earnings ratio is 4; this is 89.04% lower than that of the median Healthcare stock.
- Over the past 206 months, INVA's price/sales ratio has gone down 124.5.
- Over the past 206 months, INVA's EV/EBIT ratio has gone up 11.2.
Below are key valuation metrics over time for INVA.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| INVA | 2021-08-31 | 2.9 | 3.2 | 4.0 | 4.0 |
| INVA | 2021-08-30 | 2.9 | 3.2 | 4.0 | 4.0 |
| INVA | 2021-08-27 | 2.8 | 3.1 | 3.8 | 3.9 |
| INVA | 2021-08-26 | 2.8 | 3.1 | 3.8 | 3.8 |
| INVA | 2021-08-25 | 2.8 | 3.1 | 3.9 | 3.9 |
| INVA | 2021-08-24 | 3.0 | 3.3 | 4.1 | 4.1 |
INVA Growth Metrics
- Its 4 year cash and equivalents growth rate is now at 131.91%.
- The 2 year price growth rate now stands at -3.17%.
- The 3 year revenue growth rate now stands at 270.36%.
The table below shows INVA's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2021-06-30 | 365.494 | 328.559 | 265.192 |
| 2021-03-31 | 343.634 | 323.739 | 253.088 |
| 2020-12-31 | 336.794 | 313.113 | 224.402 |
| 2020-09-30 | 322.289 | 294.738 | 216.448 |
| 2020-06-30 | 299.35 | 277.582 | 228.039 |
| 2020-03-31 | 284.511 | 254.284 | 188.935 |
INVA's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- INVA has a Quality Grade of B, ranking ahead of 76.94% of graded US stocks.
- INVA's asset turnover comes in at 0.385 -- ranking 121st of 677 Pharmaceutical Products stocks.
- AERI, ACOR, and CALA are the stocks whose asset turnover ratios are most correlated with INVA.
The table below shows INVA's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.385 | 1 | 0.331 |
| 2021-03-31 | 0.353 | 1 | 0.337 |
| 2020-12-31 | 0.375 | 1 | 0.336 |
| 2020-09-30 | 0.389 | 1 | 0.354 |
| 2020-06-30 | 0.390 | 1 | 0.363 |
| 2020-03-31 | 0.402 | 1 | 0.302 |
INVA Price Target
For more insight on analysts targets of INVA, see our INVA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $10.00 | Average Broker Recommendation | 2.5 (Moderate Sell) |
INVA Stock Price Chart Interactive Chart >
INVA Price/Volume Stats
| Current price | $16.51 | 52-week high | $16.72 |
| Prev. close | $16.24 | 52-week low | $9.21 |
| Day low | $16.12 | Volume | 606,800 |
| Day high | $16.56 | Avg. volume | 653,791 |
| 50-day MA | $14.97 | Dividend yield | N/A |
| 200-day MA | $12.96 | Market Cap | 1.15B |
Innoviva, Inc. (INVA) Company Bio
Innoviva is a biopharmaceutical company. The Company develops small molecule medicines for respiratory disease, bacterial infections, and gastrointestinal disorders. The company was founded in 1996 and is based in South San Francisco, California.
Latest INVA News From Around the Web
Below are the latest news stories about Innoviva Inc that investors may wish to consider to help them evaluate INVA as an investment opportunity.
Innoviva Reports Second Quarter 2021 Financial ResultsBURLINGAME, Calif., July 28, 2021--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" and "the Company") today reported financial results for the second quarter ended June 30, 2021. |
Have Insiders Been Buying Innoviva, Inc. (NASDAQ:INVA) Shares?We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The... |
Are Institutions Heavily Invested In Innoviva, Inc.'s (NASDAQ:INVA) Shares?A look at the shareholders of Innoviva, Inc. ( NASDAQ:INVA ) can tell us which group is most powerful. Large companies... |
Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $20 Million Private Placement with InnovivaArmata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that, following a vote in favor of the transaction by the Armata shareholders, the Company has completed the closing of the second and final tranche of the Company's $20 million private placement of its common stock with Innoviva Strategic Opportunities LLC, a wholly-owned subsidiary of Innoviva, Inc. (NASDAQ: INVA) (together, "Innoviva"). In connection with the second closing, Armata issued 4,285,935 common shares and 4,285,935 warrants with an exercise price of $3.25 per share, at a per unit price of $3.25 per unit, in exchange for gross proce... |
Moving Average Crossover Alert: InnovivaInnoviva (INVA) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front. |
INVA Price Returns
| 1-mo | 5.56% |
| 3-mo | 22.66% |
| 6-mo | 38.62% |
| 1-year | 47.61% |
| 3-year | 10.43% |
| 5-year | 44.07% |
| YTD | 33.25% |
| 2020 | -12.50% |
| 2019 | -18.85% |
| 2018 | 22.97% |
| 2017 | 32.62% |
| 2016 | 1.52% |
Continue Researching INVA
Want to do more research on Innoviva Inc's stock and its price? Try the links below:Innoviva Inc (INVA) Stock Price | Nasdaq
Innoviva Inc (INVA) Stock Quote, History and News - Yahoo Finance
Innoviva Inc (INVA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...